Company / Total Assets
AYTU BIOPHARMA, INC Total Assets History
FY2015-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$124.2M
FY2025
5-year range
$118.1M / $265.7M
FY2021-FY2025
Trend
+5.2%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Total Assets returned to growth in FY2025 after 3 years of decline, reaching $124M.
Based on SEC 10-K filings.
$124M in FY2025 with a 10-year CAGR of +21.2%.
Declined from $136M to $124M over the past 2 years.
Total Assets over time
Growth rates
- 3-Year CAGR
- -3.4%
- 5-Year CAGR
- -4.1%
- 10-Year CAGR
- +21.2%
Key checks
Key Insights
- 5-year CAGR of -4.1%, indicating a declining trend.
- In FY2025, total assets increased 5.2% year-over-year.
- Peak total assets was recorded in FY2021.
- Lowest total assets in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score -1.77 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $124.2M | +5.2% |
| FY2024 | $118.1M | -13.5% |
| FY2023 | $136.5M | -0.8% |
| FY2022 | $137.6M | -48.2% |
| FY2021 | $265.7M | +73.3% |
| FY2020 | $153.3M | +627.9% |
| FY2018 | $21.1M | +40.4% |
| FY2017 | $15.0M | -38.4% |
| FY2016 | $24.3M | +33.9% |
| FY2015 | $18.2M | +187979.2% |
As of FY2025 · SEC Form 10-K · Last checked Jun 21, 2026